Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00177008
Status:
COMPLETED
Last Update Posted:
2007-01-29
First Post:
2005-09-13
Brief Title:
Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety
Sponsor:
University of Medicine and Dentistry of New Jersey
Organization:
Rutgers The State University of New Jersey
Study Overview
Official Title:
Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety
Status:
COMPLETED
Status Verified Date:
2007-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will determine the efficacy of a medication switch to Aripiprazole for the treatment of schizophrenia or schizoaffective disorder in patients with moderate to high symptoms of social anxiety Specifically the study will test the possibility that a medication switch to Aripiprazole reduces symptoms of social anxiety in this patient population
Detailed Description:
Although research has shown that social anxiety is very common among patients suffering from schizophrenia or schizoaffective disorder it is rarely diagnosed and treated in this patient population This study will determine the efficacy of a medication switch to Aripiprazole for the treatment of schizophrenia in patients with moderate to high symptoms of social anxiety Specifically the study will test the possibility that a medication switch to Aripiprazole reduces symptoms of social anxiety in this patient population In addition the study will test the possibility that Aripiprazole significantly improves social adjustment quality of life and level of functioning in these patients The study may also assess the ability of Aripiprazole to reduce sexual dysfunction
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None